Grov Christian, Kelly Brian C, Parsons Jeffrey T
Center for HIV/AIDS Educational Studies and Training, New York, USA.
Subst Use Misuse. 2009;44(6):848-64. doi: 10.1080/10826080802484702.
The Club Drugs and Health Project was supported by a grant from the National Institute on Drug Abuse (R01-DA014925-02, Jeffrey T. Parsons, Principal Investigator). Christian Grov was supported as a postdoctoral fellow in the Behavioral Sciences training in drug abuse research program sponsored by Public Health Solutions and the National Development and Research Institutes, Inc. (NDRI) with funding from the National Institute on Drug Abuse (T32 DA07233). The authors recognize the contributions of the Club Drug and Health Project team-Michael Adams, Virginia Andersen, Anthony Bamonte, Jessica Colon, Armando Fuentes, Sarit A. Golub, Chris Hietikko, Eda Inan, Juline Koken, Jose E. Nanin, Anthony Surace, Julia Tomassilli, Jon Weiser, Brooke E. Wells, and the recruitment team. An earlier version of this paper was presented at the 2008 meeting of the College on Problems of Drug Dependence (CPDD). Though some researchers have indicated club drug users are more likely to be polydrug users, there remains little known about the prevalence and specific combinations of the substances they use. Between 2004 and 2006, and using time-space sampling, a stratified sample of 400, 18-29-year-old New York City club-going, drug-using young adults were recruited into the Club Drugs and Health Project. Most participants (91.7%) had engaged in polydrug usage and 1,670 combinations of drugs were reported. Ecstasy (86.6% of users) and cocaine (85.7% of users) were the two most-frequently reported club drugs used in combination with other substances. In terms of poly-club drug combinations, ecstasy appeared to be the "universal compliment" as this drug was most often cited in combinations with other club drugs (specifically ecstasy + ketamine, ecstasy + cocaine, ecstasy + gamma hydroxybutyrate or GHB). Other frequently cited drug combinations included cocaine and marijuana, ecstasy and marijuana, LSD and marijuana, and cocaine and alcohol. These data highlight the need to develop drug health-education and prevention messages targeted at polydrug usage.
“俱乐部毒品与健康项目”由美国国家药物滥用研究所提供的一笔拨款资助(R01-DA014925-02,杰弗里·T·帕森斯为首席研究员)。克里斯蒂安·格罗夫作为博士后研究员,参与了由公共卫生解决方案公司和国家发展与研究机构(NDRI)发起的药物滥用研究行为科学培训项目,该项目由美国国家药物滥用研究所提供资金(T32 DA07233)。作者认可“俱乐部毒品与健康项目”团队——迈克尔·亚当斯、弗吉尼亚·安德森、安东尼·巴蒙特、杰西卡·科隆、阿曼多·富恩特斯、萨里特·A·戈卢布、克里斯·希蒂科、埃达·伊南、朱琳·科肯、何塞·E·纳宁、安东尼·苏拉斯、朱莉娅·托马西利、乔恩·韦泽、布鲁克·E·韦尔斯以及招募团队所做出的贡献。本文的一个早期版本曾在2008年药物依赖问题学会(CPDD)会议上发表。尽管一些研究人员指出,俱乐部毒品使用者更有可能是多药滥用者,但对于他们所使用物质的流行程度及具体组合,人们仍然知之甚少。在2004年至2006年期间,采用时空抽样方法,从纽约市400名年龄在18至29岁、常去俱乐部且有吸毒行为的年轻人中选取分层样本,纳入“俱乐部毒品与健康项目”。大多数参与者(91.7%)有过多药滥用行为,共报告了1670种药物组合。摇头丸(86.6%的使用者)和可卡因(85.7%的使用者)是报告中与其他物质联合使用最为频繁的两种俱乐部毒品。就多俱乐部毒品组合而言,摇头丸似乎是“万能搭配”,因为这种毒品最常与其他俱乐部毒品联合使用(特别是摇头丸+氯胺酮、摇头丸+可卡因、摇头丸+γ-羟基丁酸或GHB)。其他经常被提及的毒品组合包括可卡因和大麻、摇头丸和大麻、LSD和大麻以及可卡因和酒精。这些数据凸显了针对多药滥用制定毒品健康教育和预防信息的必要性。